HIV Dermatology
Exploring predictors of ARV adherence among HIV positive women in North America
Mike Gifford, MBA President & CEO, ARCW Anna Wuerth, MSW, LISW-S Director of Healthcare Operations, ARC Ohio Richard Womack, MSW, LCSW Executive Director,
Background: HIV and disclosure
L EGAL I SSUES FOR AN A GING HIV P OPULATION Presented by Legal Action Center 2015 Legal Action Center 1.
Discovery of New Antibodies Against HIV A Case Study of a Global Partnership Prof. Omu Anzala Program Director Kenya AIDS Vaccine Initiative (KAVI) Department.
OVERCOMING BARRIERS FOR PEOPLE WITH CRIMINAL RECORDS LEGAL ACTION CENTER 2014 1.
HIV AND THE SKIN. Seborrhoeic dermatitis Only 1-3% of the general population have seborrhoeic dermatitis compared with 20-85% of patients with HIV. Seborrhoeic.
HIV AND THE SKIN
Lynda Tyer-Viola PhD RN, Kathleen Sullivan PhD RN, Paula Reid PhD RN, Inge Corless PhD RN FAAN, Patrice Nicholas PhD RN FAAN, and A. J. Guarino PhD HIV.
Assessment of possible outlets for distribution of HIV oral self-test kits in Kenya
